Vanadium-free Ti-based high- and medium-entropy alloys as next-generation biomedical implant materials: a critical review
Nada Hamad , Ahmed Abbas , Rusul Ghadban , Mohammed Abdulrehman , Khairunisak Abdul Razak , Ahmed Hafedh Mohammed , Ali Flayyih , Ali Salman
AIMS Bioengineering ›› 2026, Vol. 13 ›› Issue (1) : 136 -167.
Load-bearing biomedical implants in severe physiological environments must compromise mechanical compatibility, corrosion resistance, and long-term biocompatibility. The fear of the long-term liberation of vanadium and aluminum has provoked the creation of vanadium-free options, despite Ti-6Al-4V remaining clinically viable. This has proved promising, with high- and medium-entropy alloys (HEAs/MEAs) of titanium containing non-toxic two stabilizing elements such as Nb, Ta, Mo, and Zr. Concentrating on the interdependent nature of alloy composition, microstructural development, phase stability, corrosion characteristics, ion release, and biological response, the present critical review article discusses vanadium-free Ti-based HEAs/MEAs and their potential use in biomedical implants. Ti-based HEAs/MEAs have been found to possess low elastic modulus values, corrosion resistance (owing to the presence of multicomponent passive oxide films), and good in vitro cytocompatibility compared to conventional Ti-6Al-4V alloys. This review highlights that microstructural heterogeneity, particularly in additively produced alloys, may have a significant influence on corrosion and biological performance, and that high configurational entropy is not sufficient to ensure improved performance. The challenges that are left to overcome include the lack of standardized testing procedures and long-term in vivo validation. This review presents research priorities so that the clinical translation of vanadium-free Ti-based HEAs/MEAs to be used in load-bearing applications is carried out safely.
Vanadium-free alloys / high-entropy alloys / medium-entropy alloys / biomedical implants / corrosion resistance / biocompatibility / complex concentrated alloys / multi-principal element alloys
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
Wei A, Diao G, Dai R, |
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
Leuders S, Thöne M, Riemer A, |
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
Takeuchi A, Amiya K, Wada T, |
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
Harcuba P, Šmilauerová J, Hájek M, |
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
Perrin A, Sorescu M, Burton MT, |
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
ASTM International (2019) ASTM F3306—19: Standard test method for ion release evaluation of medical implants. ASTM International, West Conshohocken, PA. Available from: https://store.astm.org/f3306—19.html |
| [122] |
|
| [123] |
Bărbînţă AC, Mareci D, Chelariu R, |
| [124] |
|
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
ISO (2004) ISO 16429:2004. Implants for surgery—Measurements of open—circuit potential to assess corrosion behaviour of metallic implantable materials and medical devices over extended time periods. ISO, Geneva. Available from: https://www.iso.org/standard/30288.html |
| [131] |
ISO (2009) ISO 10993—5:2009. Biological evaluation of medical devices—Part 5: Tests for in vitro cytotoxicity. ISO, Geneva. Available from: https://www.iso.org/standard/36406.html |
| [132] |
|
| [133] |
|
| [134] |
Morita A, Fukui H, Tadano H, |
| [135] |
|
| [136] |
Fukui H, Yang W, Yamada S, |
| [137] |
|
| [138] |
|
| [139] |
|
| [140] |
|
| [141] |
|
| [142] |
|
| [143] |
|
| [144] |
|
| [145] |
|
| [146] |
|
| [147] |
|
| [148] |
|
| [149] |
|
| [150] |
|
| [151] |
|
| [152] |
|
| [153] |
|
| [154] |
|
| [155] |
|
| [156] |
Crosby KD (2013) Titanium—6Aluminum—4Vanadium for functionally graded orthopedic implant applications [PhD thesis].University of Connecticut, Storrs. Available from: https://digitalcommons.lib.uconn.edu/dissertations/218 |
| [157] |
|
| [158] |
|
| [159] |
|
| [160] |
|
| [161] |
|
| [162] |
|
| [163] |
|
| [164] |
|
| [165] |
ISO (2021) ISO 5832—3:2021. Implants for surgery—Metallic materials—Part 3: Wrought titanium 6—aluminium 4—vanadium alloy (Edition 5). ISO, Geneva Available from: https://www.iso.org/standard/79626.html |
| [166] |
FDA (2017) Technical considerations for additive manufactured medical devices: Guidance for industry and Food and Drug Administration staff. U.S. Food & Drug Administration. Available from: https://www.fda.gov/regulatory—information/search—fda—guidance—documents/technical—considerations—additive—manufactured—medical—devices |
/
| 〈 |
|
〉 |